Phenylbutazone liver injury: A clinical‐pathologic survey of 23 cases and review of the literature
Stanley B. Benjamin, Kamal G. Ishak, Hyman J. Zimmerman, Amos Grushka – 1 May 1981 – Phenylbutazone has been reported to produce several forms of hepatic injury. A clinical and histologic review of 23 well‐substantiated cases in conjunction with review of 43 case reports in the literature was undertaken. Utilizing the histologic features and available clinical data, the injury was classified as moderate‐marked hepatocellular injury, minor hepatocellular injury, and other injury. No sexual differences were noted. Most patients had used the drug for less than 6 weeks.